A Allué-Guardia, JB Torrelles, A Sigal - Frontiers in Immunology, 2023 - frontiersin.org
Mycobacterium tuberculosis (M. tb) and SARS-CoV-2 are both infections that can lead to severe disease in the lower lung. However, these two infections are caused by very different …
KL Hilligan, S Namasivayam, A Sher - Frontiers in Immunology, 2023 - frontiersin.org
The observation of reduced COVID-19 incidence and severity in populations receiving neonatal intradermal BCG vaccination vaccine raised the question of whether BCG can …
BD Williams, D Ferede, HFM Abdelaal… - Frontiers in …, 2024 - frontiersin.org
At the beginning of the COVID-19 pandemic those with underlying chronic lung conditions, including tuberculosis (TB), were hypothesized to be at higher risk of severe COVID-19 …
Many studies have focused on SARS-CoV-2 and Mycobacterium tuberculosis (Mtb) co- infection consequences. However, after a vaccination plan against COVID-19, the cases of …
γδ T cells are unconventional cells involved in innate and adaptive immunity. They are able to respond rapidly and have roles in a range of diseases. The tuberculosis (TB) vaccine …
Mycobacterium tuberculosis, the causative agent of tuberculosis (TB), infects a quarter of the world population resulting in an average of 1.5 million deaths annually. Mycobacterium …